MedPath
HSA Approval

Sevoflurane Inhalation Anaesthetic Liquid 100%

SIN13741P

Sevoflurane Inhalation Anaesthetic Liquid 100%

Sevoflurane Inhalation Anaesthetic Liquid 100%

November 26, 2009

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INHALANT

RESPIRATORY (INHALATION)

Medical Information

N01AB08

sevoflurane

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

Baxter Healthcare Corporation

Active Ingredients

Sevoflurane

1ml/ml

Sevoflurane

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sevoflurane Inhalation Anaesthetic Liquid 100% - HSA Approval | MedPath